Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
The two pyrazolon derivatives, phenylbutazone and sulfinpyrazone, selectively inhibit chemotactic peptide-induced effects on neutrophils. As they antagonize the induction of acute neutropenia in vivo and of cellular hyperadhesiveness, lysosomal enzyme release, hexose monophosphate shunt activity, an...
Zapisane w:
| Wydane w: | J Clin Invest |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Clinical Investigation
1980
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371522/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7430350/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109955 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|